Purpose: Elective urological procedures require pre-operative urine assessments. Coordinating this is time consuming and is usually carried out by junior doctors leading to lack of clinical exposure/work satisfaction, overtime, late cancellations, and poor antibiotic management. This study evaluates the impact of delegating pre-operative urine management to clinical pharmacists to determine whether this intervention reduces surgery cancellations, lowers financial costs, and enhances satisfaction among patients and staff. Methodology: A clinical pharmacist was recruited to coordinate and review pre-operative urine and blood tests from February to December 2022. Same period in 2021 was compared during which junior doctors managed the pre-operative urine process. Data were collected on cancellation rates, financial costs, and satisfaction levels through a survey. Results: All preventable cancellations due to UTIs significantly decreased from 13 cases in 2021 to one case in 2022. Financially, the pharmacist-led model reduced annual costs from AUD 82,821 to 76,525, resulting in a saving of AUD 6,296, and generated additional income through activity unit generation. Staff (n=28) satisfaction with the pharmacist's service was high, with 86% agree that the pharmacist should continue to perform this role and all reported that the pharmacist improved the overall service efficiency. Patient (n=26) satisfaction with the pharmacist participation was similarly favourable at 88%. Conclusion: Integrating clinical pharmacists into pre-operative care offers administrative, clinical and financial benefits. This model alleviates the workload of junior doctors and provides a scalable solution for enhancing peri-operative care in urology units.